Its shot is a combination of Menveo and its Bexsero MenB vaccine and is being tested in a 3,650-subject study due to generate results this month, according to its clinicaltrials.gov listing.

The novel models they developed could predict two key factors: which MenB vaccine strategy could avert the most cases, and what the maximum vaccine cost for the NHS should be for the programme to be ...

In 2007, when the MenB vaccine was still in clinical trials, a research team led by Dr Hannah Christensen (School of Social and Community Medicine) developed new mathematical models to predict the ...

and particularly the dominance of Bexsero, which has been something of a pathfinder shot for MenB around the world. The company has previously suggested that the 5-in-1 vaccine could eventually ...

If under the age of 23, a quadrivalent meningococcal conjugate vaccine (MCV4) on or after your 16th birthday. Acceptable versions: Menactra, Menveo, or MCV4. Non-acceptable versions: Bexsero or ...

Teenagers receive the MenACWY vaccine in school years nine and ten. The MenB vaccine, marketed as Bexsero, is produced by GSK while the MenC vaccine component is part of a combination vaccine ...